-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Ovintiv, Raises Price Target to $72

Benzinga·10/27/2026 16:56:37
Listen to the news
Goldman Sachs analyst Neil Mehta maintains Ovintiv (NYSE:OVV) with a Buy and raises the price target from $65 to $72.